Literature DB >> 18940358

Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate.

Carol Chahine1, Moira S Cheung, Timothy W Head, Stéphane Schwartz, Francis H Glorieux, Frank Rauch.   

Abstract

Osteonecrosis of the jaw (ONJ) has been described as a complication of bisphosphonate therapy in adults. In the present study, we did not find a case of ONJ among 278 pediatric patients who had received intravenous pamidronate during childhood or adolescence.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18940358     DOI： 10.1016/j.jpeds.2008.05.003

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  16 in total

1.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

2.  Approach to the child with fractures.

Authors:  Alison M Boyce; Rachel I Gafni
Journal:  J Clin Endocrinol Metab       Date:  2011-07       Impact factor: 5.958

Review 3.  Osteogenesis imperfecta: diagnosis and treatment.

Authors:  A Biggin; C F Munns
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

4.  Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study.

Authors:  T Hasegawa; N Ueda; S I Yamada; S Kato; E Iwata; S Hayashida; Y Kojima; M Shinohara; I Tojo; H Nakahara; T Yamaguchi; T Kirita; H Kurita; Y Shibuya; S Soutome; M Akashi
Journal:  Osteoporos Int       Date:  2021-05-17       Impact factor: 4.507

5.  Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw.

Authors:  Evelina Maines; Elena Monti; Francesco Doro; Grazia Morandi; Paolo Cavarzere; Franco Antoniazzi
Journal:  J Bone Miner Metab       Date:  2011-11-08       Impact factor: 2.626

6.  Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients.

Authors:  Giampiero I Baroncelli; Francesco Vierucci; Silvano Bertelloni; Paola Erba; Elisa Zampollo; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2013-04-03       Impact factor: 2.626

Review 7.  Tooth dentin defects reflect genetic disorders affecting bone mineralization.

Authors:  S Opsahl Vital; C Gaucher; C Bardet; P S Rowe; A George; A Linglart; C Chaussain
Journal:  Bone       Date:  2012-01-26       Impact factor: 4.398

Review 8.  Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Toshihiko Nagata; Masahiro Urade; Takahiko Shibahara; Satoru Toyosawa
Journal:  J Bone Miner Metab       Date:  2016-12-29       Impact factor: 2.626

Review 9.  The management of osteoporosis in children.

Authors:  L M Ward; V N Konji; J Ma
Journal:  Osteoporos Int       Date:  2016-04-28       Impact factor: 4.507

10.  Bisphosphonates therapy in children with Osteogenesis imperfecta: clinical experience in oral surgery.

Authors:  G Ierardo; M Bossù; G D'Angeli; M Celli; G Sfasciotti
Journal:  Oral Implantol (Rome)       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.